Active Pharmaceutical Ingredient (API) Prequalified
M
Dolutegravir (sodium) manufactured by M/s.
WHO's Public Assessment Reports (WHOPAR) Update
IVD
Between 27 May and 19 June 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequa
Update on EUL for Bundibugyo Virus IVDs
IVD
WHO has published an update on the status of ongoing Emergency Use Listing (EUL) applications for in vitro diagnostics (IVDs) for Bundibugyo virus disease (BDBV).
Dolutegravir tablets manufactured by RV Life Sciences Prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Mepro’s Praziquantel tablet Prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Hetero’s Darunavir (ethanolate)/Ritonavir, FDC tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Prequalification workshop for manufacturers of IVDs
IVD
A WHO workshop brought together manufacturers of IVDs, to advance access to quality-assured diagnostics, with a focus on strengthening understanding of prequalification req
EUL for IVDs – Bundibugyo virus (BDBV) nucleic acid detection
IVD